In this regard inhibiting p38MAPK may be superior to interfering with NFκB signaling, which efficiently blocked inflammation during intestinal ischemia/reperfusion but at the same time also caused severe damage to the reperfused mucosa due to the lack of NFκB survival activity[44]. This evidence concerns the gene NFKB1 and ischemia.